Artigo Acesso aberto Revisado por pares

Corilagin and 1,3,6-Tri- O -galloy-β- d -glucose: potential inhibitors of SARS-CoV-2 variants

2021; Royal Society of Chemistry; Volume: 23; Issue: 27 Linguagem: Inglês

10.1039/d1cp01790j

ISSN

1463-9084

Autores

Vincent Binette, Sébastien Côté, Mohamed Haddad, Phuong Nguyen, Sébastien Bélanger, Steve Bourgault, Charles Ramassamy, Roger Gaudreault, Normand Mousseau,

Tópico(s)

Berberine and alkaloids research

Resumo

The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations.

Referência(s)